Aibstracts
Use case · Pharma HEOR & Market Access

Evidence strategy without the SLR bottleneck

Run systematic literature reviews and evidence landscapes that inform submissions, reimbursement strategy, and comparator decisions without compromising appraisal consistency or traceability.

Who this supports
  • HEOR Director Outcome evidence, comparator narratives, payer logic.
  • Market Access Director Reimbursement support, value story, external scrutiny.
The problem

Evidence strategy cannot wait months for an SLR

HEOR and evidence teams run SLRs, evidence landscape reviews, and gap analyses on tight timelines. Speed usually means outsourcing the work or cutting methodological corners. Neither is acceptable when the output feeds submissions and strategy.

  • SLRs that take months and lock up specialists
  • Appraisal consistency that varies by reviewer and vendor
  • Evidence landscapes outdated by the time they land
  • Synthesis hard to trace back to source for QC
How Aibstracts fits

Hand off the mechanical work. Stay in control where it is methodological

Landscapes on demand

You scope a body of literature on demand, so evidence strategy rests on what the field shows right now, not last quarter.

SLRs that stop blocking decisions

The mechanical work runs while your specialists keep control of the methodology, and full-text reading starts from a ranked priority list instead of waiting on complete screening.

Consistency you can prove

The same published decision rules apply to every study, so appraisal quality no longer depends on which reviewer or vendor did the work.

QC without the archaeology

Every extracted fact and judgment links back to its source, so quality checks read the trail instead of reconstructing someone else’s reasoning.

  • PRISMA-ready workflow
  • Reviewer-controlled decisions
  • Source-grounded outputs
  • Consistency you can audit
  • Audit trail across the review
For teams whose evidence has to hold up

Put a live SLR on the clock

Book a workflow demo with a question your team needs answered.

Thirty minutes with the founder, no sales qualification call first